Hemophilia A or B Clinical Trial
Official title:
A MULTICENTER, OPEN-LABEL, MULTIPLE ASCENDING DOSE STUDY TO EVALUATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS, PHARMACODYNAMICS, AND EFFICACY OF SUBCUTANEOUS OR INTRAVENOUS PF-06741086 IN SUBJECTS WITH SEVERE HEMOPHILIA
This study is designed to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics and efficacy of multiple subcutaneous and/or intravenous doses of PF-06741086 in subjects with severe hemophilia.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03363321 -
PF-06741086 Long-term Treatment in Severe Hemophilia
|
Phase 2 |